bromocriptine has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Hamidianjahromi, A; Tritos, NA | 1 |
Auyeung, M; Cheung, CM; Lee, CN; Li, R; Tang, WK; Tsoi, TH; Yeung, E | 1 |
Carriero, NJ; Gorelick, DA; Hall, GW; Montoya, ID; Preston, KL; Takushi, RY | 1 |
1 review(s) available for bromocriptine and Disruptive, Impulse Control, and Conduct Disorders
Article | Year |
---|---|
Impulse control disorders in hyperprolactinemic patients on dopamine agonist therapy.
Topics: Bromocriptine; Cabergoline; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms | 2022 |
1 trial(s) available for bromocriptine and Disruptive, Impulse Control, and Conduct Disorders
Article | Year |
---|---|
Pathological gambling among cocaine-dependent outpatients.
Topics: Adolescent; Adult; Age of Onset; Ambulatory Care; Bromocriptine; Bupropion; Carbamazepine; Cocaine-Related Disorders; Comorbidity; Disruptive, Impulse Control, and Conduct Disorders; Female; Gambling; Humans; Length of Stay; Male; Middle Aged; Prevalence; Psychiatric Status Rating Scales; Substance Abuse Detection; Substance Abuse Treatment Centers; Treatment Outcome | 2000 |
1 other study(ies) available for bromocriptine and Disruptive, Impulse Control, and Conduct Disorders
Article | Year |
---|---|
Impulse control disorders in Chinese Parkinson's disease patients: the effect of ergot derived dopamine agonist.
Topics: Aged; Antiparkinson Agents; Asian People; Bromocriptine; China; Cross-Sectional Studies; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug Therapy, Combination; Ergot Alkaloids; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies | 2011 |